 | • レポートコード：GIR-2104Z01030 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アンチトロンビンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アンチトロンビンの種類別市場規模（液体、凍結乾燥）、用途別市場規模（診断、治療、研究）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アンチトロンビンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Grifols、rEVO Biologics Inc.、Takeda、Kedrion S.p.A.、CSL Limited、Scripps Laboratories Inc.、Lee Biosolutions ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：液体、凍結乾燥 ・用途別分析2016年-2026年：診断、治療、研究 ・アンチトロンビンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アンチトロンビンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アンチトロンビンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アンチトロンビンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アンチトロンビンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antithrombin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antithrombin size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Antithrombin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Antithrombin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liquid
Lyophilized
Market segment by Application can be divided into
Diagnostics
Therapeutics
Research
The key market players for global Antithrombin market are listed below:
Grifols
rEVO Biologics Inc.
Takeda
Kedrion S.p.A.
CSL Limited
Scripps Laboratories Inc.
Lee Biosolutions
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Antithrombin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antithrombin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Liquid
1.2.3 Lyophilized
1.3 Market Analysis by Application
1.3.1 Overview: Global Antithrombin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Diagnostics
1.3.3 Therapeutics
1.3.4 Research
1.4 Global Antithrombin Market Size & Forecast
1.4.1 Global Antithrombin Sales in Value (2016-2026))
1.4.2 Global Antithrombin Sales in Volume (2016-2026)
1.4.3 Global Antithrombin Price by Type (2016-2026) & (US$/Unit)
1.5 Global Antithrombin Production Capacity Analysis
1.5.1 Global Antithrombin Total Production Capacity (2016-2026)
1.5.2 Global Antithrombin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antithrombin Market Drivers
1.6.2 Antithrombin Market Restraints
1.6.3 Antithrombin Trends Analysis
2 Manufacturers Profiles
2.1 Grifols
2.1.1 Grifols Details
2.1.2 Grifols Major Business
2.1.3 Grifols Antithrombin Product and Services
2.1.4 Grifols Antithrombin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 rEVO Biologics Inc.
2.2.1 rEVO Biologics Inc. Details
2.2.2 rEVO Biologics Inc. Major Business
2.2.3 rEVO Biologics Inc. Antithrombin Product and Services
2.2.4 rEVO Biologics Inc. Antithrombin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Antithrombin Product and Services
2.3.4 Takeda Antithrombin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Kedrion S.p.A.
2.4.1 Kedrion S.p.A. Details
2.4.2 Kedrion S.p.A. Major Business
2.4.3 Kedrion S.p.A. Antithrombin Product and Services
2.4.4 Kedrion S.p.A. Antithrombin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 CSL Limited
2.5.1 CSL Limited Details
2.5.2 CSL Limited Major Business
2.5.3 CSL Limited Antithrombin Product and Services
2.5.4 CSL Limited Antithrombin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Scripps Laboratories Inc.
2.6.1 Scripps Laboratories Inc. Details
2.6.2 Scripps Laboratories Inc. Major Business
2.6.3 Scripps Laboratories Inc. Antithrombin Product and Services
2.6.4 Scripps Laboratories Inc. Antithrombin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Lee Biosolutions
2.7.1 Lee Biosolutions Details
2.7.2 Lee Biosolutions Major Business
2.7.3 Lee Biosolutions Antithrombin Product and Services
2.7.4 Lee Biosolutions Antithrombin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Antithrombin Sales by Manufacturer
3.1 Global Antithrombin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Antithrombin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Antithrombin
3.4 Market Concentration Rate
3.4.1 Top 3 Antithrombin Manufacturer Market Share
3.4.2 Top 6 Antithrombin Manufacturer Market Share
3.5 Global Antithrombin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Antithrombin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antithrombin Market Size by Region
4.1.1 Global Antithrombin Sales in Volume by Region (2016-2026)
4.1.2 Global Antithrombin Revenue by Region (2016-2026)
4.2 North America Antithrombin Revenue (2016-2026)
4.3 Europe Antithrombin Revenue (2016-2026)
4.4 Asia-Pacific Antithrombin Revenue (2016-2026)
4.5 South America Antithrombin Revenue (2016-2026)
4.6 Middle East and Africa Antithrombin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Antithrombin Sales in Volume by Type (2016-2026)
5.2 Global Antithrombin Revenue by Type (2016-2026)
5.3 Global Antithrombin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Antithrombin Sales in Volume by Application (2016-2026)
6.2 Global Antithrombin Revenue by Application (2016-2026)
6.3 Global Antithrombin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Antithrombin Sales by Type (2016-2026)
7.2 North America Antithrombin Sales by Application (2016-2026)
7.3 North America Antithrombin Market Size by Country
7.3.1 North America Antithrombin Sales in Volume by Country (2016-2026)
7.3.2 North America Antithrombin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Antithrombin Sales by Type (2016-2026)
8.2 Europe Antithrombin Sales by Application (2016-2026)
8.3 Europe Antithrombin Market Size by Country
8.3.1 Europe Antithrombin Sales in Volume by Country (2016-2026)
8.3.2 Europe Antithrombin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Antithrombin Sales by Type (2016-2026)
9.2 Asia-Pacific Antithrombin Sales by Application (2016-2026)
9.3 Asia-Pacific Antithrombin Market Size by Region
9.3.1 Asia-Pacific Antithrombin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Antithrombin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Antithrombin Sales by Type (2016-2026)
10.2 South America Antithrombin Sales by Application (2016-2026)
10.3 South America Antithrombin Market Size by Country
10.3.1 South America Antithrombin Sales in Volume by Country (2016-2026)
10.3.2 South America Antithrombin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antithrombin Sales by Type (2016-2026)
11.2 Middle East & Africa Antithrombin Sales by Application (2016-2026)
11.3 Middle East & Africa Antithrombin Market Size by Country
11.3.1 Middle East & Africa Antithrombin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Antithrombin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Antithrombin Typical Distributors
12.3 Antithrombin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Antithrombin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Antithrombin Revenue by Application, (USD Million), 2021-2026
Table 3. Grifols Basic Information, Manufacturing Base and Competitors
Table 4. Grifols Major Business
Table 5. Grifols Antithrombin Product and Services
Table 6. Grifols Antithrombin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. rEVO Biologics Inc. Basic Information, Manufacturing Base and Competitors
Table 8. rEVO Biologics Inc. Major Business
Table 9. rEVO Biologics Inc. Antithrombin Product and Services
Table 10. rEVO Biologics Inc. Antithrombin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Takeda Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Major Business
Table 13. Takeda Antithrombin Product and Services
Table 14. Takeda Antithrombin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Kedrion S.p.A. Basic Information, Manufacturing Base and Competitors
Table 16. Kedrion S.p.A. Major Business
Table 17. Kedrion S.p.A. Antithrombin Product and Services
Table 18. Kedrion S.p.A. Antithrombin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 20. CSL Limited Major Business
Table 21. CSL Limited Antithrombin Product and Services
Table 22. CSL Limited Antithrombin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Scripps Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Scripps Laboratories Inc. Major Business
Table 25. Scripps Laboratories Inc. Antithrombin Product and Services
Table 26. Scripps Laboratories Inc. Antithrombin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Lee Biosolutions Basic Information, Manufacturing Base and Competitors
Table 28. Lee Biosolutions Major Business
Table 29. Lee Biosolutions Antithrombin Product and Services
Table 30. Lee Biosolutions Antithrombin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Antithrombin Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Antithrombin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Antithrombin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Antithrombin Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Antithrombin Production Site of Key Manufacturer
Table 36. Global Antithrombin Sales by Region (2016-2021e) & (K Units)
Table 37. Global Antithrombin Sales by Region (2021-2026) & (K Units)
Table 38. Global Antithrombin Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Antithrombin Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Antithrombin Sales by Type (2016-2021e) & (K Units)
Table 41. Global Antithrombin Sales by Type (2021-2026) & (K Units)
Table 42. Global Antithrombin Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Antithrombin Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Antithrombin Price by Type (2016-2021e) & (US$/Unit)
Table 45. Global Antithrombin Price by Type (2021-2026) & (US$/Unit)
Table 46. Global Antithrombin Sales by Application (2016-2021e) & (K Units)
Table 47. Global Antithrombin Sales by Application (2021-2026) & (K Units)
Table 48. Global Antithrombin Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Antithrombin Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Antithrombin Price by Application (2016-2021e) & (US$/Unit)
Table 51. Global Antithrombin Price by Application (2021-2026) & (US$/Unit)
Table 52. North America Antithrombin Sales by Country (2016-2021e) & (K Units)
Table 53. North America Antithrombin Sales by Country (2021-2026) & (K Units)
Table 54. North America Antithrombin Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Antithrombin Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Antithrombin Sales by Type (2016-2021e) & (K Units)
Table 57. North America Antithrombin Sales by Type (2021-2026) & (K Units)
Table 58. North America Antithrombin Sales by Application (2016-2021e) & (K Units)
Table 59. North America Antithrombin Sales by Application (2021-2026) & (K Units)
Table 60. Europe Antithrombin Sales by Country (2016-2021e) & (K Units)
Table 61. Europe Antithrombin Sales by Country (2021-2026) & (K Units)
Table 62. Europe Antithrombin Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Antithrombin Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Antithrombin Sales by Type (2016-2021e) & (K Units)
Table 65. Europe Antithrombin Sales by Type (2021-2026) & (K Units)
Table 66. Europe Antithrombin Sales by Application (2016-2021e) & (K Units)
Table 67. Europe Antithrombin Sales by Application (2021-2026) & (K Units)
Table 68. Asia-Pacific Antithrombin Sales by Region (2016-2021e) & (K Units)
Table 69. Asia-Pacific Antithrombin Sales by Region (2021-2026) & (K Units)
Table 70. Asia-Pacific Antithrombin Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Antithrombin Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Antithrombin Sales by Type (2016-2021e) & (K Units)
Table 73. Asia-Pacific Antithrombin Sales by Type (2021-2026) & (K Units)
Table 74. Asia-Pacific Antithrombin Sales by Application (2016-2021e) & (K Units)
Table 75. Asia-Pacific Antithrombin Sales by Application (2021-2026) & (K Units)
Table 76. South America Antithrombin Sales by Country (2016-2021e) & (K Units)
Table 77. South America Antithrombin Sales by Country (2021-2026) & (K Units)
Table 78. South America Antithrombin Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Antithrombin Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Antithrombin Sales by Type (2016-2021e) & (K Units)
Table 81. South America Antithrombin Sales by Type (2021-2026) & (K Units)
Table 82. South America Antithrombin Sales by Application (2016-2021e) & (K Units)
Table 83. South America Antithrombin Sales by Application (2021-2026) & (K Units)
Table 84. Middle East & Africa Antithrombin Sales by Country (2016-2021e) & (K Units)
Table 85. Middle East & Africa Antithrombin Sales by Country (2021-2026) & (K Units)
Table 86. Middle East & Africa Antithrombin Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Antithrombin Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Antithrombin Sales by Type (2016-2021e) & (K Units)
Table 89. Middle East & Africa Antithrombin Sales by Type (2021-2026) & (K Units)
Table 90. Middle East & Africa Antithrombin Sales by Application (2016-2021e) & (K Units)
Table 91. Middle East & Africa Antithrombin Sales by Application (2021-2026) & (K Units)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Antithrombin Typical Distributors
Table 95. Antithrombin Typical Customers
List of Figures
Figure 1. Antithrombin Picture
Figure 2. Global Antithrombin Sales Market Share by Type in 2020
Figure 3. Liquid
Figure 4. Lyophilized
Figure 5. Global Antithrombin Sales Market Share by Application in 2020
Figure 6. Diagnostics
Figure 7. Therapeutics
Figure 8. Research
Figure 9. Global Antithrombin Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Antithrombin Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Antithrombin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Antithrombin Sales (2016-2026) & (K Units)
Figure 31. Global Antithrombin Production Capacity (2016-2026) & (K Units)
Figure 32. Global Antithrombin Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Antithrombin Market Drivers
Figure 34. Antithrombin Market Restraints
Figure 35. Antithrombin Market Trends
Figure 36. Global Antithrombin Sales Market Share by Manufacturer in 2020
Figure 37. Global Antithrombin Revenue Market Share by Manufacturer in 2020
Figure 38. Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Antithrombin Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Antithrombin Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Antithrombin Sales Market Share by Region (2016-2026)
Figure 42. Global Antithrombin Revenue Market Share by Region (2016-2026)
Figure 43. North America Antithrombin Revenue (2016-2026) & (USD Million)
Figure 44. Europe Antithrombin Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Antithrombin Revenue (2016-2026) & (USD Million)
Figure 46. South America Antithrombin Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Antithrombin Revenue (2016-2026) & (USD Million)
Figure 48. Global Antithrombin Sales Market Share by Type (2016-2026)
Figure 49. Global Antithrombin Revenue Market Share by Type (2016-2026)
Figure 50. Global Antithrombin Price by Type (2016-2026) & (US$/Unit)
Figure 51. Global Antithrombin Sales Market Share by Application (2016-2026)
Figure 52. Global Antithrombin Revenue Market Share by Application (2016-2026)
Figure 53. Global Antithrombin Price by Application (2016-2026) & (US$/Unit)
Figure 54. North America Antithrombin Sales Market Share by Country (2016-2026)
Figure 55. North America Antithrombin Revenue Market Share by Country (2016-2026)
Figure 56. North America Antithrombin Sales Market Share by Type (2016-2026)
Figure 57. North America Antithrombin Sales Market Share by Application (2016-2026)
Figure 58. Europe Antithrombin Sales Market Share by Country (2016-2026)
Figure 59. Europe Antithrombin Revenue Market Share by Country (2016-2026)
Figure 60. Europe Antithrombin Sales Market Share by Type (2016-2026)
Figure 61. Europe Antithrombin Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Antithrombin Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Antithrombin Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Antithrombin Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Antithrombin Sales Market Share by Application (2016-2026)
Figure 66. South America Antithrombin Sales Market Share by Country (2016-2026)
Figure 67. South America Antithrombin Revenue Market Share by Country (2016-2026)
Figure 68. South America Antithrombin Sales Market Share by Type (2016-2026)
Figure 69. South America Antithrombin Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Antithrombin Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Antithrombin Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Antithrombin Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Antithrombin Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の救命救急治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Critical Care Therapeutics Market The global Critical Care Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …- 世界の脳卒中診断＆治療市場規模・現状・予測（2021年-2027年） Stroke refers to the brain attack. Stroke occurs when the supply of blood to the brain is either interrupted or reduced. Increasing number of mergers and acquisitions, rapid product launches, and rise in number of collaborations and partnerships are some of the latest trends that have been observed …
- 世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年） Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014. Market Analysis and Insights: Glob…
- 世界の動物用治療・診断市場規模・現状・予測（2021年-2027年） Diagnostic instruments aid in the determination of causative agents of diseases. The animal therapeutics and diagnostics market is growing at a steadypace due tothe increase in pet ownership worldwide, especiallyin the developing countries. Market Analysis and Insights: Global Animal Therapeutics a…
- 世界の睡眠無呼吸診断・治療市場規模・現状・予測（2021年-2027年） Sleep apnea or Sleep disordered breathing (SDB) is a disorder that is characterised by brief interruptions in breathing or shallow breathing during sleep. Obstructive Sleep Apnea (OSA) is the most common type of sleep apnea.Sleep Apnea Diagnostics and Therapeutics are a serial of methods and medical…